Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
暂无分享,去创建一个
T. Kishimoto | N. Nishimoto | T. Miyamae | M. Mori | S. Takei | S. Yokota | T. Imagawa | H. Imanaka | N. Iwata | T. Murata | Y. Nerome | M. Miyoshi